Role of biological and non biological factors in congestive heart failure mortality: PREDICE-SCORE: A clinical prediction rule

Cardiology Journal

Volumn 19, Issue 6, 2012, Pages 578-585

  De la Cámara, Agustín Gómez ^a,d   Guerra Vales, Juan Manuel ^a   Tapia, Purificación Magán ^a   Esteban, Eva Andrés ^a,d   del Pozo, Silvia Vázquez Fernández ^a,d   Sandubete, Enrique Calderón ^b,d   Ortega, Francisco J Medrano ^b,d   Puerto, Asunción Navarro ^c   Marín León, Ignacio ^b,d  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Heart failure; Predictive rules; Prognosis; Systolic dysfunction

Indexed keywords

BIOLOGICAL MARKER; CREATININE; SODIUM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHEMICAL ANALYSIS; CLINICAL DECISION MAKING; CLINICAL STUDY; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CREATININE CLEARANCE; DAILY LIFE ACTIVITY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; POINT OF CARE TESTING; PREDICE SCORING SYSTEM; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROCESS DEVELOPMENT; PROCESS MODEL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY PREVENTION; SOCIAL ASPECT; SODIUM BLOOD LEVEL; SYSTOLIC DYSFUNCTION; TERTIARY HEALTH CARE;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOLOGICAL MARKERS; COHORT STUDIES; CREATININE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALS, UNIVERSITY; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SODIUM; SPAIN; SURVIVAL RATE; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84873884924     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: 10.5603/CJ.2012.0108     Document Type: Article

References (49)

1. Curtis LH, Whellan DJ, Hammill BG et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med, 2008; 168: 418-424.
2. Kannel WB. Incidence and epidemiology of heart failure. Heart Failure Rev, 2000; 2: 167-173.
3. McMurray JJV, Stewart S. The burden of heart failure. Eur Heart J, 2002; 4 (suppl. D): d50-d58.
4. Pilnick A, Dignwall R, Starkey K. Disease management: Definitions, difficulties and future directions. Bulletin of the World Health Organization, 2001; 79: 755-763.
5. Wagner EH. Chronic disease care. BMJ, 2004; 328: 177-178.
6. McAlister F, Stewart S, Ferrua S, McMurray JJV. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials. J Am Coll Cardiol, 2004; 44: 810-819.
7. Göhler A, Januzzi JL, Worrell SS et al. A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail, 2006; 12: 554-567.
8. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure):Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by Heart Rhythm Society. Circulation, 2005; 112: e154-e235.
9. Dickstein K, Cohen-Solal A, Filippatos G et al.; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008; 29: 2388-2442.
10. Levy WC, Mozzafarian D, Linker DT et al. The Seattle Heart Model: Prediction of survival in heart failure. Circulation, 2006; 113: 1424-1433.
11. Pocock SJ, Wang D, Pfeffer MA et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J, 2006; 27: 65-75.
12. Huynh BC, Rovner A, Rich MW. Long-term survival in elderly patients hospitalized for heart failure: 14-year follow-up from prospective randomized trial. Arch Intern Med, 2006; 166: 1892-1898.
13. Cicoira M, Maggioni AP, Latini R et al.; Val-HeFT Investigators. Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial. Eur J Heart Fail, 2007; 9: 397-402.
14. Gustafsson F, Kragelund C, Torp-Pedersoen C et al.; DIAMOND Study Group. Effect of obesity and being overweight on longterm mortality in congestive heart failure: Influence of left ventricular systolic function. Eur Heart J, 2005; 26: 58-64.
15. Senni M, Tribouilloy CM, Rodeheffer RJ et al. Congestive heart failure in the community: Trends in incidence and survival in a 10-year period. Arch Intern Med, 1999; 159: 29-34.
16. Muzzarelli S, Leibundgut G, Maeder MT et al.; TIME-CHF Investigators. Predictors of early readmission or death in elderly patients with heart failure. Am Heart J, 2010; 160: 308-314.
17. Novack V, Pencina M, Zahger D et al. Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute descompensated heart failure. PloS One, 2010; 5: e12184.
18. Senni M, Santilli G, Parrella P et al. A novel prognostic index to determine the impact of cardiac conditions and comorbidities on one-year outcome in patients with heart failure. Am J Cardiol, 2006; 98: 1076-1082.
19. Smith GL, Shlipak MG, Havranek EP et al. Serum urea nitrogen, creatinine and estimators of renal function. Mortality in older patients with cardiovascular disease. Arch Intern Med, 2006; 166: 1134-1142.
20. Hillege HL, Nitsch D, Pfeffer M et al.; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcomes in a broad spectrum of patients with heart failure. Circulation, 2006; 113: 671-678.
21. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: A population-based study. Arch Intern Med, 2002; 162: 1689-1694.
22. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of clinical model. JAMA, 2003; 290: 2581-2587.
23. O'Connor CM, Abraham WT, Albert NM et al. Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Life-saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J, 2008; 156: 662-673.
24. Hoffman M, Bauer R, Handrock R, Weindinger G, Goedel-Meinen L. Prognostic value of the QRS duration in patients with heart failure: A subgroup analysis from 24 centers of Val-HeFT. J Cardiac Fail, 2005; 11: 523-528.
25. Solomon SD, Anavekar N, Skali H et al. Candersartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation, 2005; 112: 3738-3744.
26. Martínez-Sellés M, García Robles JA, Prieto L et al. Características de los pacientes ingresados por insuficiencia cardíaca según el estado de su función ventricular. Rev Esp Cardiol, 2002; 55: 579-586.
27. Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf SA. A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med, 2004; 116: 300-304.
28. Curtis JP, Rathore SS, Wang Y, Krumholz HM. The association of a 6-minute walk performance and outcomes in stable outpatients with heart failure. J Card Fail, 2004; 10: 9-14.
29. Braunstein JB, Anderson GF, Gerstenblith G et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol, 2003; 42: 1226-1233.
30. Siirilä-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola VP; FINN-AKVA Study Group. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J, 2006; 27: 3011-3017.
31. Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term survival after heart failure: A contemporary population-based perspective. Arch Intern Med, 2007; 167: 490-496.
32. Schmaltz HN, Southern D, Ghali WA et al. Living alone, patient sex and mortality after acute myocardial infarction. J Gen Intern Med, 2007; 22: 572-578.
33. Nielsen FE, Mard S. Single-living is associated with increased risk of long-term mortality among employed patients with acute myocardial infarction. Clinical Epidemiol, 2010; 2: 91-98.
34. Tsuchihashi M, Tsutsui H, Kodama K et al. Medical and Socioenviromental predictors of Hospital readmission in patients with congestive heart failure. Am Heart J, 2001; 142: E7.
35. Rodríguez-Artalejo F, Guallar-Castillón P, Conde Herrera M et al. Social network as a predictor of hospital readmission and mortality among older patients with heart failure. J Card Fail, 2006; 12: 621-627.
36. Frassure-Smith N, Lespérance F et al. Social support, depression and mortality during the first year after myocardial infarction. Circulation, 2000; 101: 1919-1924.
37. Dickens CM, McGowan L, Pervical C et al. Lack of close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart, 2004; 90: 518-522.
38. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J, 1965; 14: 61-65.
39. Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist, 1969; 9:179-186.
40. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med, 2004; 23: 1631-1660.
41. Permanyer Miralda G, Soriano N et al. Características basales y evolución de pacientes ingresados por insuficiencia cardiaca. Rev Esp Cardiol, 2002; 55: 571-578.
42. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort. J Am Coll Cardiol, 1999; 33: 1948-1955.
43. Mosterd A, Cost B, Hoes AW et al. The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J, 2001; 22: 1318-1327.
44. Rodríguez-Artalejo F, Guallar-Castillón P, Banegas Banegas JR, Rey Calero J. Trends in hospitalizations and mortality for heart failure in Spain, 1980-1993. Eur Heart J, 1997; 18: 1771-1779.
45. Cowie MR, Wood DA, Coats AJ et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart, 2000; 83: 505-510.
46. Mahon NG, Blackstone EH, Francis GS. Starling RC, Young JB, Lauer MS. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol, 2002; 40: 1106-1113.
47. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort study. Circulation, 2004; 109: 1004-1009.
48. Alter DA, Chong A, Austin PC et al.; SESAMI Study Group. Socioeconomic status and mortality after acute myocardial infarction. Ann Intern Med, 2006; 144: 82-93.
49. Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med, 2010; 7: e1000316.